122 related articles for article (PubMed ID: 15723277)
1. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice.
Sobue T; Naganawa T; Xiao L; Okada Y; Tanaka Y; Ito M; Okimoto N; Nakamura T; Coffin JD; Hurley MM
J Cell Biochem; 2005 May; 95(1):83-94. PubMed ID: 15723277
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling.
Jiang J; Lichtler AC; Gronowicz GA; Adams DJ; Clark SH; Rosen CJ; Kream BE
Bone; 2006 Sep; 39(3):494-504. PubMed ID: 16644298
[TBL] [Abstract][Full Text] [Related]
3. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
4. Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation.
Zhang M; Faugere MC; Malluche H; Rosen CJ; Chernausek SD; Clemens TL
J Bone Miner Res; 2003 May; 18(5):836-43. PubMed ID: 12733722
[TBL] [Abstract][Full Text] [Related]
5. Deletion of membrane-bound steel factor results in osteopenia in mice.
Lotinun S; Evans GL; Turner RT; Oursler MJ
J Bone Miner Res; 2005 Apr; 20(4):644-52. PubMed ID: 15765184
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
Kim J; Xing W; Wergedal J; Chan JY; Mohan S
Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
[TBL] [Abstract][Full Text] [Related]
7. Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model.
Rantakokko J; Uusitalo H; Jämsä T; Tuukkanen J; Aro HT; Vuorio E
J Bone Miner Res; 1999 Nov; 14(11):1934-42. PubMed ID: 10571694
[TBL] [Abstract][Full Text] [Related]
8. Preproenkephalin (Penk) is expressed in differentiated osteoblasts, and its deletion in Hyp mice partially rescues their bone mineralization defect.
Seitz S; Barvencik F; Gebauer M; Albers J; Schulze J; Streichert T; Amling M; Schinke T
Calcif Tissue Int; 2010 Apr; 86(4):282-93. PubMed ID: 20204609
[TBL] [Abstract][Full Text] [Related]
9. Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K.
Kiviranta R; Morko J; Uusitalo H; Aro HT; Vuorio E; Rantakokko J
J Bone Miner Res; 2001 Aug; 16(8):1444-52. PubMed ID: 11499867
[TBL] [Abstract][Full Text] [Related]
10. Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice.
Sakagami N; Amizuka N; Li M; Takeuchi K; Hoshino M; Nakamura M; Nozawa-Inoue K; Udagawa N; Maeda T
Micron; 2005; 36(7-8):688-95. PubMed ID: 16182547
[TBL] [Abstract][Full Text] [Related]
11. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
12. Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.
Günther T; Poli C; Müller JM; Catala-Lehnen P; Schinke T; Yin N; Vomstein S; Amling M; Schüle R
EMBO J; 2005 Sep; 24(17):3049-56. PubMed ID: 16079911
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast-specific expression of MEF induces osteopenia through downregulation of osteoblastogenesis and upregulation of osteoclastogenesis.
Seul KJ; Cho HS; Heo SH; Baek WY; Kim JE; Park EK; Choi JY; Ryoo HM; Cho JY
J Bone Miner Res; 2011 Feb; 26(2):341-50. PubMed ID: 20715187
[TBL] [Abstract][Full Text] [Related]
14. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
15. Actions of fibroblast growth factor-8 in bone cells in vitro.
Lin JM; Callon KE; Lin JS; Watson M; Empson V; Tong PC; Grey A; Naot D; Green CR; Reid IR; Cornish J
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E142-50. PubMed ID: 19383871
[TBL] [Abstract][Full Text] [Related]
16. The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells.
Boban I; Jacquin C; Prior K; Barisic-Dujmovic T; Maye P; Clark SH; Aguila HL
Bone; 2006 Dec; 39(6):1302-12. PubMed ID: 16938497
[TBL] [Abstract][Full Text] [Related]
17. Targeted overexpression of vitamin D receptor in osteoblasts increases calcium concentration without affecting structural properties of bone mineral crystals.
Misof BM; Roschger P; Tesch W; Baldock PA; Valenta A; Messmer P; Eisman JA; Boskey AL; Gardiner EM; Fratzl P; Klaushofer K
Calcif Tissue Int; 2003 Sep; 73(3):251-7. PubMed ID: 14667138
[TBL] [Abstract][Full Text] [Related]
18. Femoral peak bone mass and osteoclast number in an animal model of age-related spontaneous osteopenia.
Okamoto Y; Takahashi K; Toriyama K; Takeda N; Kitagawa K; Hosokawa M; Takeda T
Anat Rec; 1995 May; 242(1):21-8. PubMed ID: 7604978
[TBL] [Abstract][Full Text] [Related]
19. Alteration of noncollagenous bone matrix proteins in distal renal tubular acidosis.
Disthabanchong S; Domrongkitchaiporn S; Sirikulchayanonta V; Stitchantrakul W; Karnsombut P; Rajatanavin R
Bone; 2004 Sep; 35(3):604-13. PubMed ID: 15336595
[TBL] [Abstract][Full Text] [Related]
20. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro.
Zhang W; Pantschenko AG; McCarthy MB; Gronowicz G
Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]